Hebei Biopharmaceutical

Hebei Medical University Biopharmaceutical Co., Ltd. is a specialized biopharmaceutical enterprise based in Shijiazhuang, China, primarily focused on the development and production of vaccines and biological products. Established in 1988 and affiliated with Hebei Medical University, the company has become a leading manufacturer of the Brucellosis vaccine (Live, S2 strain), which is critical for public health and animal husbandry in China. The company operates multiple GMP-certified production lines and integrates research, development, and commercialization of biological products, including various veterinary vaccines and diagnostic reagents. As a recognized high-tech enterprise, it maintains strong academic ties with Hebei Medical University to drive innovation in immunology and infectious disease prevention. Its facilities are equipped for large-scale fermentation and lyophilization, serving both domestic and international markets.